Is cannabis a viable alternative for patients with AS resistant to other treatments? 

For those who find limited relief from conventional therapies, medical cannabis use is becoming an area of growing interest. Patients with ankylosing spondylitis who are resistant to NSAIDs, biologics, or physical therapy often explore cannabis as a complementary or standalone option. 

While full-scale trials are still catching up, emerging effectiveness data and patient reports suggest cannabis can help with pain, sleep, and overall quality of life. A formal clinical comparison to biologics is still lacking, but for many, the perceived benefits justify trying cannabis, especially when side effects or diminishing returns limit traditional choices. 

Cannabis as an Alternative Option 

Targeted symptom relief 

Cannabis may ease pain and improve rest even when inflammation persists under other treatments. 

Adaptable treatment approach 

Dosing, strain selection, and timing can be personalised to each patient’s symptoms and response. 

Financial considerations 

Treatment costs are usually out-of-pocket, which may deter some patients unless benefits are clear. 

Growing data support 

Though more clinical comparison studies are needed, real-world feedback offers promising leads. 

Visit providers like LeafEase to learn if medical cannabis use may be a viable option in your AS care plan, particularly when other treatments fall short. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Ankylosing Spondylitis and medical cannabis.